Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2010
07/21/2010CN101181602B Chinese medicine preparation, preparation method thereof as well as application in the preparation of antiviral and antibacterial drugs
07/21/2010CN101181534B Traditional Chinese medicine preparation for curing tetanus
07/21/2010CN101181304B Liquid for preventing and curing fowl plague poultry influenza
07/21/2010CN101177451B Micrococcus pyogenes adhesion functional peptide and coded sequence thereof
07/21/2010CN101058535B Di(7-hydrxyl-2,3-dihydro-1-1H-indeno)ether and the like, synthetic method and application
07/21/2010CN101036662B Medicament for treating beriberi and its preparation and medical bar
07/20/2010US7759488 Monoazole ligand platinum analogs
07/20/2010US7759486 2,4,5-Trisubstituted pyrimidine compounds
07/20/2010US7759477 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics
07/20/2010US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor
07/20/2010US7759362 1-cyclopropyl-8-difluoromethoxyl-7-[(1S,6S)-2,8-diazabicyclo[4,3,0]nonane-8-yl]-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride, having potent antibacterial activity against broad-spectrum pathogenic bacteria, with favorable pharmacokinetics and very low toxicity
07/20/2010US7759354 Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof
07/20/2010US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus
07/20/2010US7759324 Antiadhesive carbohydrates
07/20/2010US7759323 Highly purified antiendotoxin compound
07/20/2010US7759116 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced
07/20/2010US7759070 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
07/20/2010US7758893 Enteral compositions for the prevention and/or treatment of sepsis
07/20/2010US7758887 Warming and nonirritating lubricant compositions and method of comparing irritation
07/20/2010US7758876 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
07/20/2010US7758875 Vaccine
07/20/2010US7758869 Immunization of animal; mixture with solid phase lipid; oral administering
07/20/2010US7758863 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
07/20/2010US7758856 Bacteriophage for the treatment of bacterial biofilms
07/20/2010US7758852 OX40R binding agents
07/20/2010CA2547234C The use of quaternary pyridinium salts as vasoprotective agents
07/20/2010CA2532049C Isethionate salt of a selective cdk4 inhibitor
07/20/2010CA2502416C N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
07/20/2010CA2472685C Method of treatment of gastrointestinal disease and polymeric composition for use therein
07/20/2010CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
07/20/2010CA2447865C Novel sulfonic acid derivatives
07/20/2010CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis
07/20/2010CA2350651C Novel erythromycin derivatives, preparation method and use as medicines
07/20/2010CA2322487C Novel prodrugs for phosphorus-containing compounds
07/20/2010CA2290136C New erythromycin derivatives, the process for preparing them and their use as a drug product
07/20/2010CA2289980C Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
07/20/2010CA2271249C Macromolecular neuraminidase-binding compounds
07/20/2010CA2197563C Capsular polysaccharide immunomodulator
07/20/2010CA2191063C Dna encoding glutamate gated chloride channels
07/20/2010CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it
07/15/2010WO2010081082A2 Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
07/15/2010WO2010080878A1 Combination of a cyclosporine derivative and nucleosides for treating hcv
07/15/2010WO2010080874A1 Cyclosporine derivative for use in the treatment of hcv and hiv infection
07/15/2010WO2010080782A2 Random homozygous gene perburbation (rhgp) with thermal assymetric interlaced (tail)-pcr
07/15/2010WO2010080572A1 Treatment or prevention of viral infection by chlorination
07/15/2010WO2010080455A1 New salts
07/15/2010WO2010080389A1 Hcv ns3 protease inhibitors
07/15/2010WO2010080188A2 Epitope targeted anthrax vaccine
07/15/2010WO2010079858A1 Novel bacteria-specific lysine proteins with broad antibacterial activity
07/15/2010WO2010079421A1 Use of deuterium oxide for treating viral diseases of the eye
07/15/2010WO2010079420A1 Use of deuterium oxide for treating viral diseases of the respiratory tract
07/15/2010WO2010079224A1 Pharmaceutical composition to protect an animal against a disorder arising from an infection with a bacterium that belongs to the group of nocardioform actinomycetes
07/15/2010WO2010078830A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
07/15/2010WO2010078660A1 Use of proanthocyanidins as an anti-apoptotic agent and anti-adhesive bacterial agent
07/15/2010WO2010057101A3 Compounds useful as hiv blockers
07/15/2010WO2010056100A3 Kit of pharmaceutical formulations characterised by the presence of molecular oxygen
07/15/2010WO2010049454A3 Antimicrobial composition from copepods
07/15/2010WO2010025448A3 Compounds for inhibiting cell proliferation
07/15/2010WO2010023207A3 Antimicrobial agents
07/15/2010WO2009103821A3 Regulators of pb1-f2 activity for treating virus infections
07/15/2010US20100179207 Compounds
07/15/2010US20100179189 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
07/15/2010US20100179174 Substituted azaquinazolines having an antiviral action
07/15/2010US20100179170 Heterogeneously configured multiparticulate gastrointestinal drug delivery system
07/15/2010US20100179161 Pyrazoline derivatives for the treatment of turberculosis
07/15/2010US20100179152 Novel use for PDE5 inhibitors
07/15/2010US20100179150 Antibacterial piperdine derivatives
07/15/2010US20100179145 Pharmaceutical combinations
07/15/2010US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments
07/15/2010US20100179135 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
07/15/2010US20100179123 Thienopyrimidines useful as aurora kinase inhibitors
07/15/2010US20100179122 Non-Nucleoside Reverse Transcriptase Inhibitors
07/15/2010US20100179119 Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold
07/15/2010US20100179116 Arene Connected Polyamine Macrocyclic Derivatives, Preparation Methods and Pharmaceutical Uses Thereof
07/15/2010US20100179109 Renin inhibitors
07/15/2010US20100179101 Novel Crystalline Forms Of An Antiviral Benzimidazole Compound
07/15/2010US20100179100 Medicinal forms of phospholipid preparations and methods for their preparation
07/15/2010US20100178365 Epicatechin deficient green tea
07/15/2010US20100178354 Remedy
07/15/2010US20100178345 Hydrogel Microparticle Composition, Application Thereof and Method for Preparing the Same
07/15/2010US20100178340 Tableted compositions containing atazanavir
07/15/2010US20100178339 Tableted compositions containing atazanavir
07/15/2010US20100178337 Composition comprising an active agent with low aqueous solubility
07/15/2010US20100178330 Asymmetric liposomes and uses in medical field thereof
07/15/2010US20100178325 Amphiphilic nucleotide cochleate compositions and methods of using the same
07/15/2010US20100178303 Stable organic-carrier-based microbial inoculants and method for producing the same
07/15/2010US20100178302 Chronic pathogen-expressing cell lines
07/15/2010US20100178295 Compositions and methods for the therapy and diagnosis of influenza
07/15/2010US20100178275 Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics
07/15/2010US20100178272 Structure and use of 5'phosphate oligonucleotides
07/15/2010US20100178255 Composition and method to treat otitis media and ventilator- associated pneumonia
07/15/2010US20100175796 Anti fungal and anti-microbial protection for storage items and protective covers
07/15/2010DE102009004959A1 Use of at least one transaminase inhibitor for producing an agent for the prophylaxis and treatment of pityriasis versicolor
07/15/2010DE102009003974A1 Oral high-dose vitamin K1-containing preparation, useful for increasing the resistance of the human organism against influenza infection
07/15/2010CA2750785A1 Random homozygous gene perburbation (rhgp) with thermal assymetric interlaced (tail)-pcr
07/15/2010CA2750227A1 Cyclosporine derivative for use in the treatment of hcv and hiv infection
07/15/2010CA2749394A1 Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
07/15/2010CA2749174A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses